Table 2.
Day 19 |
Day 43 |
|||
---|---|---|---|---|
Vehicle ± SD | 125 mg/kg/day ± SD | Vehicle ± SD | 125 mg/kg/day ± SD | |
Hematologic Parameter | ||||
NeutroHephil | 0.95 ± 0.443* F | 0.37 ± 0.08 F | 1.81 ± 0.567 M | 0.76 ± 0.057 M |
Reticulocytes | 2.88 ± 0.997** F | 1.46 ± 0.219 F | 2.39 ± 0.656 F | 1.39 ± 0.354 F |
Monocytes | 0.55 ± 0.186 M | 0.14 ± 0.028 M | ||
LUC | ||||
Eosinophils | 0.08 ± 0.032 | 0.14 ± 0.045 | ||
Biochemistry Parameter | ||||
Creatinine | 28.40 ± 1.563 M | 35.58 ± 1.450 M | ||
Urea | ||||
Glucose | 5.76 ± 0.534 M | 7.75 ± 1.041** M | ||
Triglyceride | 0.51 ± 0.151 M | 0.21 ± 0.037* M | 0.82 ± 0.339 M | 0.18 ± 0.071 M |
ALAT | 39 ± 4.3 M | 59 ± 6.4* M | 47 ± 10.2 M | 34 ± 3.5 M |
Blood parameter changes were observed at the end of the treatment period (day 19, n = 5/sex/group) and at the end of the recovery period (day 43, n = 3/sex/group) as measured in the animal group treated with 125 mg/kg/day of LNA-i-miR-221 or in the control (vehicle) group. M, male; F, female. *p < 0.01, **p < 0.05.